ES2176254T3 - Procedimiento para encapsular farmacos anti-informatorios no esteroideos. - Google Patents

Procedimiento para encapsular farmacos anti-informatorios no esteroideos.

Info

Publication number
ES2176254T3
ES2176254T3 ES94925799T ES94925799T ES2176254T3 ES 2176254 T3 ES2176254 T3 ES 2176254T3 ES 94925799 T ES94925799 T ES 94925799T ES 94925799 T ES94925799 T ES 94925799T ES 2176254 T3 ES2176254 T3 ES 2176254T3
Authority
ES
Spain
Prior art keywords
microencapsulation
masked
taste
water
microcapsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94925799T
Other languages
English (en)
Inventor
Sambasiva Rao Ghanta
Robert Edmon Guisinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adare Pharma Solutions Inc
Original Assignee
Eurand America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand America Inc filed Critical Eurand America Inc
Application granted granted Critical
Publication of ES2176254T3 publication Critical patent/ES2176254T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ESTA DESCRIPCION ESTA DIRIGIDA A LA PREPARACION DE MICROCAPSULAS DE ELEVADA CARGA NUCLEAR, ELEVADA BIODISPONIBILIDAD, DE SABOR ENMASCARADO E INDIVIDUALES, MEDIANTE LA MICROENCAPSULACION DE MATERIALES FARMACOLOGICOS DE NSAID INSOLUBLES EN AGUA CON LA AUSENCIA SUSTANCIAL DE AGLOMERADOS DE MICROCAPSULAS. ESTAS MICROCAPSULAS DE SABOR ENMASCARADO CONTIENEN UNA ELEVADA CARGA NUCLEAR, POR EJEMPLO APROXIMADAMENTE 83+ % EN PESO DE DICHO MATERIAL FARMACOLOGICO DE NSAID QUE POSEE UNA ELEVADA BIODISPONIBILIDAD Y QUE ENTONCES PUEDE FORMULARSE EN COMPRIMIDOS MASTICABLES Y SUSPENSIONES ACUOSAS LIQUIDAS PARA UN USO MEDICINAL. EL ACETATO FTALATO DE CELULOSA Y LA GELATINA SON EL MATERIAL DE PARED POLIMERICO PARA LA MICROENCAPSULACION. SON PARAMETROS DEL PROCEDIMIENTO IMPORTANTES EL CONTROL DEL PH, LA ADICION CONTROLADA DE UNA SAL DE HOFMEISTER (LIOTROPICA), LA MICROENCAPSULACION DEL MEDICAMENTE NSAID INSOLUBLE EN AGUA CON UNA FASE LIQUIDA DE UN MATERIAL PARA LA MICROENCAPSULACION DE ACETATO FTALATO DE CELULOSA Y GELATINA, Y LA POSTERIOR INSOLUBILIZACION DE DICHO MATERIAL PARA LA ENCAPSULACION LIQUIDO DESPUES DE QUE CUBRA EL NUCLEO DE MEDICAMENTO CON ACIDO DILUIDO, PARA LOGRAR LA MICROCAPSULAS INDIVIDUALES APROPIADAS PARA OBTENER UNOS MATERIALES FARMACOLOGICOS DE NSAID INSOLUBLES EN AGUA, DE SABOR ENMASCARADO, DE ELEVADA BIODISPONIBILIDAD, EN ESPECIAL NAPROXENO E IBUPROFENO, SOLO MEDIANTE ENCAPSULACION.
ES94925799T 1993-08-13 1994-08-09 Procedimiento para encapsular farmacos anti-informatorios no esteroideos. Expired - Lifetime ES2176254T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10602493A 1993-08-13 1993-08-13

Publications (1)

Publication Number Publication Date
ES2176254T3 true ES2176254T3 (es) 2002-12-01

Family

ID=22309067

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94925799T Expired - Lifetime ES2176254T3 (es) 1993-08-13 1994-08-09 Procedimiento para encapsular farmacos anti-informatorios no esteroideos.

Country Status (14)

Country Link
US (2) US5653993A (es)
EP (1) EP0818992B1 (es)
AT (1) ATE216578T1 (es)
AU (1) AU7559594A (es)
BR (1) BR9407246A (es)
CA (1) CA2169376C (es)
DE (1) DE69430491T2 (es)
DK (1) DK0818992T3 (es)
ES (1) ES2176254T3 (es)
IL (1) IL110621A (es)
MY (1) MY111453A (es)
PT (1) PT818992E (es)
WO (1) WO1995005166A1 (es)
ZA (1) ZA945944B (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN969796A0 (en) 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
AU719137B2 (en) * 1996-05-07 2000-05-04 Mayne Pharma International Pty Ltd Taste masked liquid suspensions
FR2753093B1 (fr) * 1996-09-06 1998-10-16 Oreal Composition de teinture d'oxydation pour fibres keratiniques comprenant un polymere amphiphile anionique
EP0929312A1 (en) 1996-09-26 1999-07-21 Oklahoma Medical Research Foundation Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
CA2457100A1 (en) * 2001-08-01 2003-02-13 Bristol-Myers Squibb Company Taste masking composition
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8603514B2 (en) * 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
AU2003220551A1 (en) * 2002-03-26 2003-10-13 Euro-Celtique S.A. Sustained-release gel coated compositions
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
ITMI20032523A1 (it) * 2003-12-19 2005-06-20 Acraf Forma di dosaggio per uso orale comprendente un farmaco
KR100694235B1 (ko) * 2005-04-21 2007-03-14 영남대학교 산학협력단 새로운 이부프로펜 함유 젤라틴 초미세 미립구
ES2651444T3 (es) 2006-10-20 2018-01-26 Johnson & Johnson Consumer Inc. Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
US20080138397A1 (en) * 2006-10-24 2008-06-12 Aradigm Corporation Processes for taste-masking of inhaled formulations
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
AU2008318851B2 (en) * 2007-10-31 2014-04-17 Mcneil-Ppc, Inc. Orally disintegrated dosage form
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8784781B2 (en) 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
JP6173912B2 (ja) * 2010-09-20 2017-08-02 エスピーアイ ファーマ，インコーポレイテッド マイクロカプセル化プロセスおよび製品
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
RU2015114433A (ru) 2012-09-18 2016-11-10 МакНЕЙЛ-ППС, ИНК. Пероральные дозированные формы с замедленным высвобождением, содержащие частицы легкоплавкого производного пропионовой кислоты
CA2884119A1 (en) 2012-09-18 2014-03-27 Mcneil-Ppc, Inc. Low melting propionic acid derivative particles for use in oral dosage forms
CA2908528C (en) 2013-03-12 2018-04-24 Panacea Biomatx, Inc. Method and system for making customized formulations for individuals
MX368159B (es) 2014-01-10 2019-09-20 Johnson & Johnson Consumer Inc Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas.
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS59193816A (ja) * 1983-04-19 1984-11-02 Morishita Jintan Kk 腸溶性軟カプセルの製造法
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IT1214629B (it) * 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
IN166447B (es) * 1985-11-27 1990-05-12 Ethicon Inc
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
IE902829A1 (en) * 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials

Also Published As

Publication number Publication date
EP0818992A1 (en) 1998-01-21
ZA945944B (en) 1996-02-08
CA2169376C (en) 2003-10-21
BR9407246A (pt) 1996-09-24
AU7559594A (en) 1995-03-14
PT818992E (pt) 2002-08-30
DK0818992T3 (da) 2002-08-19
IL110621A (en) 1999-10-28
CA2169376A1 (en) 1995-02-23
EP0818992B1 (en) 2002-04-24
US5814332A (en) 1998-09-29
US5653993A (en) 1997-08-05
IL110621A0 (en) 1994-11-11
DE69430491T2 (de) 2002-08-08
WO1995005166A1 (en) 1995-02-23
ATE216578T1 (de) 2002-05-15
DE69430491D1 (de) 2002-05-29
MY111453A (en) 2000-05-31

Similar Documents

Publication Publication Date Title
ES2176254T3 (es) Procedimiento para encapsular farmacos anti-informatorios no esteroideos.
JP4718116B2 (ja) 薬学的活性成分の遅延かつ制御された放出のための微小粒子経口ガレヌス製剤形態
CA1317883C (en) Liquid dosage form for oral administration of a pharmaceutically active substance
US4928840A (en) Tamper proof encapsulated medicaments
KR860006984A (ko) 서방성 제제의 제조방법
DE68907139D1 (de) Mikrokapsel mit verzoegerter freigabe fuer wasserloesliche arzneistoffe.
GB930422A (en) Process of the encapsulation of particulate material
WO2002034234A3 (en) Methylphenidate modified release formulations
DE637236T1 (de) Pharmazeutische zubereitung und verfahren für ihre herstellung.
EP1421989B1 (en) Microcapsule and production method thereof
EP0130162A2 (en) Small particle formation and encapsulation
EP1284137B1 (en) Nonoral preparation having three-layer structure
EP0195476A2 (en) Therapeutic particles
IE37637B1 (en) Improvements in or relating to control medicaments
KR910004184A (ko) 마이크로캡슐화된 미각-차폐된 수불용성 nsaid약제
JPS63287544A (ja) マイクロカプセルの製造法
Khode et al. Review of micrencapsulation: a review a novel approach in drug delivery
GB1436714A (en) Medicinal process
JP2001113158A (ja) 乾燥マイクロカプセルの製造方法
TH23867A (th) รูปแบบชนิดยาแคปซูล